WHO ICTRP trial
Management of type 2 diabetes with increased cardiovascular disease risk: a…
ChiCTR2000036508 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000036508 |
|---|---|
| Public title | Management of type 2 diabetes with increased cardiovascular disease risk: a multicenter randomized controlled clinical trial |
| Scientific title | Management of type 2 diabetes with increased cardiovascular disease risk: a multicenter randomized controlled clinical trial |
| Primary sponsor | Ruijin Hospital, Shanghai Jiaotong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Type 2 diabetes |
| Interventions | Intensive BP treatment and multifactorial management:Participants in the intensive BP treatment and multifactorial management group will be treated to a systolic BP target of <120 mmHg with glucose-lowering and lipid-lowering treatment… |
| Registration date | Aug 23, 2020 |
| Target size | Intensive BP treatment and multifactorial management:571;Standard BP treatment… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: